Key result
Ischemic cerebrovascular disease was associated with significantly lower mean plasma adiponectin levels compared to matched controls (4.36 vs 6.97 µg/mL, p=0.000).
Why the study?
Are plasma adiponectin levels lower in patients with ischemic cerebrovascular disease compared to controls, and do they correlate with infarction size?
Case-Control (n=80)
Yes
Are plasma adiponectin levels lower in patients with ischemic cerebrovascular disease compared to controls, and do they correlate with infarction size?
Plasma adiponectin levels are significantly lower in patients with ischemic cerebrovascular disease and negatively correlate with infarction size, suggesting a potential role in the disease process.
Answers are grounded in this paper and cite their sources.
May support adiponectin as a biomarker in ischemic cerebrovascular disease; hypothesis-generating and should not yet change practice.
OBJECTIVE: To investigate whether hypo-adiponectinemia is present in ischemic stroke patients. METHODS: This comparative study was carried out in the Biochemistry Department, Ziauddin University, Karachi, Pakistan in 2008. In this study, plasma adiponectin concentration was measured by an enzyme-linked immunosorbent assay in subjects with and without ischemic cerebrovascular disease (CVD). RESULTS: A total of 80 subjects were studied (40 patients with CVD, and 40 without CVD as controls). The mean plasma level of adiponectin of the 40 patients with ischemic CVD was significantly lower than that of the 40 subjects without CVD (4.36+/-0.21 ug/mL versus 6.97+/-0.241 ug/mL; p=0.000). Decreasing concentrations of adiponectin were negatively correlated with infarction size in ischemic CVD patients. CONCLUSION: These data show that there are significantly lower levels of plasma adiponectin in patients with ischemic CVD. Moreover, adiponectin is negatively correlated with infarction size in these patients suggesting the possible role of adiponectin in cerebrovascular disease.
No takes yet. Share an insight, caveat, or question.
Jaleel et al. (2009) conducted a case-control in Ischemic cerebrovascular disease (n=80). Ischemic cerebrovascular disease vs. Without cerebrovascular disease was evaluated on Mean plasma adiponectin concentration (µg/mL) (p=0.000). Ischemic cerebrovascular disease was associated with significantly lower mean plasma adiponectin levels compared to matched controls (4.36 vs 6.97 µg/mL, p=0.000).
Synapse has enriched 10 related papers. Consider them for comparative context: